Zemplar and c-reactive protein increased 
Zemplar and c-reactive protein increased Patient Reports February 10, 2012
Zemplar Side Effects Report #5368323-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on June 15, 2007. Male patient, weighting 135.6 lb, was diagnosed with renal osteodystrophy, cardiovascular event prophylaxis, musculoskeletal pain, hyperphosphataemia, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: back pain
, body temperature increased, c-reactive protein increased, gastroenteritis , hypercalcaemia, left ventricular dysfunction, movement disorder , musculoskeletal pain, spinal osteoarthritis. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, COXTRAL, SEVELAMER HYDROCHLORIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5708490-9
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 11, 2008. Male patient, 83 years of age, was diagnosed with renal failure chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma
, c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5730681-1
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 29, 2008. Male patient, 83 years of age, was diagnosed with renal failure chronic, pain
, atrial fibrillation , nephrogenic anaemia, constipation prophylaxis, metabolic acidosis, angina pectoris and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma , c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML ONE DOSE, 1ML. During the same period patient was treated with PARACETAMOL, DIGOXIN, EPOETIN ALFA, FUROSEMIDE, LACTULOSE, BICARBONATE, GLYCERYL TRINITRATE, PARENTROVITE. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5736763-2
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on May 08, 2008. Male patient, 83 years of age, was diagnosed with renal failure chronic, pain
, atrial fibrillation , nephrogenic anaemia, constipation prophylaxis, metabolic acidosis, angina pectoris and was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma , c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML ONE DOSE, 1ML. During the same period patient was treated with ACETAMINOPHEN, DIGOXIN, EPOETIN ALFA, FUROSEMIDE, LACTULOSE, BICARBONATE, GLYCERYL TRINITRATE, PARENTROVITE. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5176645-0
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Oct 31, 2006. Female patient, weighting 244.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, calciphylaxis, cardiac failure, diarrhoea, hyperparathyroidism secondary, international normalised ratio increased, oedema peripheral, pain in extremity, skin necrosis. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, SOTALOL HYDROCHLORIDE, FERRIECIT, GODASAL, NAHCO, CACO, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient died on 09/08/2006.
Zemplar Side Effects Report #5265323-5
Zemplar side effect was reported by a Physician from GERMANY on Mar 05, 2007. Male patient, weighting 213.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, skin necrosis, white blood cell count increased. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5288599-7
Zemplar side effect was reported by a Physician from GERMANY on Mar 27, 2007. Male patient, weighting 213.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, skin necrosis, white blood cell count increased. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5576929-8
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Dec 20, 2007. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dyspnoea, extrinsic vascular compression, pneumonia staphylococcal, staphylococcal infection
, traumatic haematoma, white blood cell count increased. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5588644-5
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Jan 02, 2008. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dyspnoea, extrinsic vascular compression, pneumonia staphylococcal, staphylococcal infection
, traumatic haematoma, white blood cell count increased. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5870795-9
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 26, 2008. Male patient, 63 years of age, was diagnosed with hyperparathyroidism, blood glucose increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain lower, blood glucose increased, blood potassium decreased, blood sodium decreased, breath sounds abnormal, c-reactive protein increased, condition aggravated, dysuria, infection
. Zemplar dosage: 5UG/ML: 2ML WEEKLY. During the same period patient was treated with CLOPIDOGREL, NOVA NORM. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5868752-1
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 26, 2008. Male patient, 60 years of age, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, episcleritis, vena cava thrombosis. Zemplar dosage: 5 MCG/ML, 1 ML ONCE A WEEK. During the same period patient was treated with OMEPRAZOLE, TRIOBE, PARENTROVITE, PYRIDOXINE HYDROCHLORIDE, CALCIUM CARBONATE, WARFARIN, METOPROLOL TARTRATE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5930177-8
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Oct 14, 2008. Male patient, 60 years of age, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, diarrhoea, episcleritis, oxygen saturation decreased, sepsis
, vena cava thrombosis. Zemplar dosage: 5 MCG/ML, 1 ML ONCE A WEEK. During the same period patient was treated with OMEPRAZOLE, TRIOBE, PARENTROVITE, PYRIDOXINE HYDROCHLORIDE, CALCIUM CARBONATE, WARFARIN, METOPROLOL TARTRATE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5863799-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 19, 2008. Female patient, 59 years of age, was diagnosed with hyperparathyroidism, dialysis
, keratoplasty and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood creatinine increased, c-reactive protein increased, cerebral infarction, fatigue, hyponatraemia, leukocytosis, oxygen saturation decreased. Zemplar dosage: unknown. During the same period patient was treated with DIAZEPAM, FLOXACILLIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5871178-8
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Sept 04, 2008. Female patient, 59 years of age, was diagnosed with hyperparathyroidism, dialysis
, keratoplasty and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood creatinine increased, c-reactive protein increased, cerebral infarction, fatigue, hyponatraemia, leukocytosis, oxygen saturation decreased. Zemplar dosage: unknown. During the same period patient was treated with DIAZEPAM, FLOXACILLIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #4843164-8
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Nov 21, 2005. Male patient, weighting 119.0 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, cough, somnolence. Zemplar dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CLOPIDOGREL BISULPHATE, CORVATON RETARD, DREISAVIT N, AMITRIPTYLINE, FENOTEROL HYDROBROMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALORON N RETARD. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #4960155-7
Zemplar side effect was reported by a Physician from GERMANY on Nov 21, 2005. Male patient, weighting 119.0 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal pain upper, agitation, anaemia, apathy, back pain
, blood pressure decreased, c-reactive protein increased, cough, dyspnoea. Zemplar dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CLOPIDOGREL BISULPHATE, CORVATON RETARD, DREISAVIT N, AMITRIPTYLINE HYDROCHLORIDE, FENOTEROL HYDROBROMIDE, METOCLOPRAMIDE HYDROCHLORIDE, VALORON N RETARD. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5692431-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Mar 28, 2008. Male patient, 83 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma
, c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient died on 03/27/2008.Zemplar Side Effects Report #5697979-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 03, 2008. Male patient, 83 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: asthma
, c-reactive protein increased, chronic obstructive pulmonary disease, dyspnoea, multi-organ failure, oedema, oxygen saturation abnormal, pneumonia . Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient died on 03/27/2008.